03-15-2019 12:36 PM CET - Health & Medicine

A Brief Overview of Cancer Gene Therapy Market | Illustrious Players - SiBiono., Shanghai Sunway Biotech company limited, Altor Bioscience Corporation, Amgen, BioCancell, Aduro Biotech, OncoGeneX, GlobeImmune, Inc., New Link Genetics., MolMed S.p.A, ZioPh

Press release from: Global Market Insights, Inc.
Cancer Gene Therapy Market
Cancer Gene Therapy Market
Cancer Gene Therapy Market size is expected to exceed USD 4.3 billion by 2024; as per a new research report by Global Market Insights, Inc. Globally, rising cancer prevalence will increase demand for gene therapy as the effective personalized treatment choice. According to WHO, cancer incidence is projected to rise by 50% to reach 15 million by the end of this decade. This alarming increase in number of patients necessitates this as a potential treatment approach addressing the growing global burden of the disease.

A significant rise in the number of cancer incidences has led to the deployment of genome technologies, which will spur Cancer Gene Therapy Market size. As per WHO estimates, the number of cancer cases is estimated to increase by 70% over the coming two decades, which will stimulate the introduction of new gene therapies. Heavy funding by the government for cancer research programs and beneficial schemes favoring cancer screening programs are expected to produce lucrative avenues for cancer gene therapy market. As per Global Market Insights, Inc., “Cancer gene therapy industry revenue, which was assessed at USD 805.5 million in 2015, is projected to hit USD 4.3 billion by 2024.”

Request sample copy of this report @ www.gminsights.com/request-sample/detail/763

Considering the regional trends, cancer gene therapy industry in China, which accounted for 35% of Asia Pacific cancer gene therapy market share in 2015, is projected to record a CAGR of 21% over the next few years, having collected a revenue of USD 99.6 million in 2015. Rapid commercialization of drugs required for cancer gene therapy coupled with enhanced developments in healthcare services will drive the regional expansion.UK cancer gene therapy industry, which was assessed at USD 92 million in 2015, is set to grow at an annual rate of 20.8% over the coming seven years, subject to high frequency of cancer among the nations’ population along with the acceptance of modern treatment methodologies. Cancer gene therapy market in Japan, worth USD 78.2 million in 2015, is projected to expand at a CAGR of 20.9% over the period from 2016 to 2024.

U.S. cancer gene therapy industry, which contributed more than 95% of North America cancer gene therapy market revenue in 2015, is projected to grow at a rate of 20.9% over the coming seven years. It had amassed an income of USD 235 million in 2015. Innovation in biotechnology and the rising acceptance of new gene technologies for cancer treatments is expected to boost the regional revenue.

Cancer gene therapies comprise gene transfer, oncolytic virotherapy, and gene induced immunotherapy. Gene transfer market size, which accounted for more than 46% of the cancer gene therapy market revenue in 2015, is projected to record a CAGR of 20.9% over the coming timeframe. This therapy helps to permanently alter the nuclear genome of the host cell and is widely deployed across the medical sector, stimulating the overall market.

Make Inquiry about this report @ www.gminsights.com/inquiry-before-buying/763

Gene induced immunotherapy industry, which contributed to 14% of cancer gene therapy market share in 2015, is slated to surpass USD 592.7 million by 2024. The growth can be attributed to its ability to effectively fight cancer cells through new gene insertion in the tumors.

Global cancer gene therapy market is highly fragmented with small biotech firms holding a chunk of the overall industry share. Key business expansion strategies such as deployment of advanced technologies, copyrights & patenting of products, strategic collaborations, and joint ventures adopted by major industry participants will help them in retaining their positions in the global business space. NewLink Genetics Corporation, ZIOPHARM Oncology Incorporation, Shenzhen Sibiono GeneTech Company Limited, Genelux Corporation, Gradalis Incorporation, Altor Bioscience Corporation, Shanghai Sunway Biotech Company Limited, Amgenen Incorporation, MultiVir Incorporation, Aduro Biotech Incorporation, OncoGeneX Pharmaceuticals Company, GlobeImmune Incorporation, MolMed S.p.A., and BioCancell Therapeutic Incorporation are the few of the established players of cancer gene therapy industry.

Report Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.1.1. Initial data exploration
1.1.2. Statistical modeling and forecast
1.1.3. Industry insights and validation
1.1.4. Research scope & assumptions
1.2. Data Sources

Chapter 2. Executive Summary
2.1. Cancer genetics industry 3600 synopsis, 2012 - 2024
2.1.1. Business trends
2.1.2. Regional trends
2.1.3. Application trends

Chapter 3. Cancer Gene Therapy Industry Insights
3.1. Industry segmentation
3.2. IIndustry Size and forecast, 2012 - 2024
3.3. Industry Impact forces
3.3.1. Growth drivers Technological advancements Increased adoption of nanotechnology Favorable government regulations
3.3.2. Industry pitfalls & challenges High cost of cancer genetherapy
3.4. Growth potential analysis
3.5. Porter’s analysis
3.6. Key opportunities prioritized, 2015
3.7. PESTEL analysis
3.8. Regulatory Landscape
3.8.1. U.S.
3.8.2. EU
3.8.3. China
3.9. Scientific and Ethical issues in Gene Therapy
3.10. Competitive landscape, 2015
3.11. Pipeline Analysis by cancer type
3.11.1. Head and Neck Cancer Pipeline Analysis
3.11.2. Breast Cancer Pipeline Analysis
3.11.3. Gastro Intestinal Cancer Pipeline Analysis
3.11.4. Gentiourinary Cancer Pipeline Analysis
3.11.5. Gynecological Cancer Pipeline Analysis
3.11.6. Haemotological Cancer Pipeline Analysis
3.11.7. Neurologic Cancer Pipeline Analysis
3.11.8. Respiratory Cancer Pipeline Analysis
3.11.9. Skin Cancer Pipeline Analysis

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : news-researchers.com/

This release was published on openPR.
News-ID: 1656922 • Views: 194
More releasesMore releases

You can edit or delete your press release here: